Connection

Pål Aukrust to Cardiomyopathy, Dilated

Back to Details
This is a "connection" page, showing publications Pål Aukrust has written about Cardiomyopathy, Dilated.
Pål Aukrust
Connection Strength
0.377
Cardiomyopathy, Dilated
  1. Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy. Sci Rep. 2017 06 14; 7(1):3490.
    View in: PubMed
    Score: 0.135
  2. The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy. J Cardiovasc Transl Res. 2017 Aug; 10(4):401-410.
    View in: PubMed
    Score: 0.134
  3. The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial. PLoS One. 2014; 9(2):e89732.
    View in: PubMed
    Score: 0.107
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.